Volume 9, Issue 5
Case Reportp. 409
Reactive arthritis following Bacillus Calmette-Gu�©rin immunotherapy
Author(s): S Cardozo, C GarcÃÂÂa, LF Pinto Peñaranda, C Muñoz-Grajales, CJ Velásquez Franco, JJ Correa & JD Márquez Hernández
Research Articlep. 415
Etanercept in moderate rheumatoid arthritis: PRESERVE study results from central/eastern Europe, Latin America and Asia
Author(s): K Pavelka, R Burgos-Vargas, P Miranda, R Guzman, J-H Yen, M Al Izzi, Z Szekanecz, B Tang, A Szumski, S Kotak, E Bananis, AS Koenig, EY Mahgoub & MU Rahman
Research Articlep. 431
Circadian variation in plasma IL-6 and the role of modified-release prednisone in polymyalgia rheumatica
Author(s): SA Zakout, LL Clarke, D Jessop, RH Straub & JR Kirwan
Research Articlep. 441
Thyroid disorders, hyperprolactinemia and systemic lupus erythematosus activity
Author(s): M Garcia-Carrasco, C Mendoza-Pinto, A Zamora-Ustaran, M Muñoz-Guarneros, LJ Jara-Quezada, LG Vazquez de Lara, O Vera-Lastra, M Jimenez-Hernandez, P Munguia-Realpozo, A Lopez-Colombo & A Ruiz-Arguelles
Perspective Articlep. 449
Perspectives on the imperatives, opportunities and challenges for point-of-care diagnostics in systemic lupus erythematosus
Author(s): MJ Fritzler
Review Articlep. 457
Rheumatoid arthritis and cardiac disease
Author(s): M Gonzalez-Mayda, D Sen & R Brasington
Review Articlep. 475
The future of biological agents in the treatment of rheumatoid arthritis
Author(s): C Rawlings & E Choy
Review Articlep. 487
Technology applications to improve health outcomes and self-management in patients with arthritis
Author(s): MD Iversen, ME Connors, MR Menapace, AJ Samson & E Tessitore
Review Articlep. 505
Update on the treatment of myositis
Author(s): S Moghadam-Kia, CV Oddis & R Aggarwal
Review Articlep. 519
Role of the Lyn tyrosine kinase in the development of autoimmune disease
Author(s): E Tsantikos, TA Gottschalk, MJ Maxwell & ML Hibbs
